Comparison of the Efficacies of Topical Liposomal Amphotericin B and Topical Clotrimazolein the Treatment of Pityriasis Versicolor

被引:1
作者
Ghahartars, Mehdi [1 ]
Hosseini, Hossein [2 ]
Khedri, Malek [1 ]
Sadati, Maryam Sadat [1 ,3 ]
机构
[1] Shiraz Univ Med Sci, Mol Dermatol Res Ctr, Dept Dermatol, Shiraz, Iran
[2] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran
[3] Shiraz Univ Med Sci, Faghihi Hosp, Mol Dermatol Res Ctr, Dermatol Dept, Zand St, Shiraz 7134846114, Iran
来源
DERMATOLOGY PRACTICAL & CONCEPTUAL | 2024年 / 14卷 / 01期
关键词
amphotericin B; clotrimazole; pityriasis versicolor; topical treatment; ORAL FLUCONAZOLE; 2-PERCENT CREAM; BLIND;
D O I
10.5826/dpc.1401a83
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Introduction: Pityriasis versicolor (PV) often exhibits recurrence even despite treatment, and a standardized therapy with a complete cure rate remains elusive. Given the fungicidal property of amphotericin B, its potential for PV treatment warrants investigation. Objectives: This study aimed to compare the efficacy of topical liposomal amphotericin B and clotrimazole cream in treating PV. Methods: A randomized controlled trial was conducted with 44 PV patients, aged 15 to 70 years, who were equally assigned to either the amphotericin or clotrimazole group. The trial was registered at the Iranian Registry of Clinical Trials on March 7th, 2022. PV diagnosis was confirmed in all patients through positive microscopic results. The amphotericin group received topical gel containing liposomal amphotericin B 0.4%, while the other group received topical cream containing clotrimazole 1%. Both treatments were applied twice daily to the affected skin lesions for 14 days. The primary outcomes assessed were mycologic cure, clinical cure, and complete cure at day 14 post-treatment. Results: Both drugs demonstrated successful treatment outcomes, with comparable rates of mycologic cure (77.3%), clinical cure (63.6%), and complete combined cure (63.6%). There was no significant difference between the groups in terms of the degree of cure (P=0.75). Adjustments for age, sex, lesion extent, and lesion site yielded insignificant risk ratio and risk difference estimates for the complete cure rate (P>0.05). Conclusions: The topical application of liposomal amphotericin B 0.4% is equally effective as topical clotrimazole 1% in treating pityriasis versicolor. These findings suggest that liposomal amphotericin B could be considered as a viable alternative treatment for PV. Further research is warranted to explore its long-term consequences and safety profile.
引用
收藏
页数:9
相关论文
共 29 条
  • [1] Ahmed N, 2017, Pak Armed Forces Med J, V67, P458
  • [2] Balwada R P, 1996, Indian J Dermatol Venereol Leprol, V62, P298
  • [3] Bamford J.T.M., 2018, Cochrane Database Syst Rev, V2018, pCD011208, DOI [10.1002/14651858.CD011208.pub2, DOI 10.1002/14651858.CD011208.PUB2]
  • [4] One-week terbinafine 1% solution in pityriasis versicolor: twice-daily application is more effective than once-daily
    Budimulja, U
    Paul, C
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2002, 13 (01) : 39 - 40
  • [5] Carlile M J, 2001, Elsevier Science, V3
  • [6] Chopra V, 2000, Indian J Dermatol Venereol Leprol, V66, P299
  • [7] Single-dose oral fluconazole versus topical clotrimazole in patients with pityriasis versicolor: A double-blind randomized controlled trial
    Dehghan, Mohammad
    Akbari, Negin
    Alborzi, Nazila
    Sadani, Somayeh
    Keshtkar, Abas A.
    [J]. JOURNAL OF DERMATOLOGY, 2010, 37 (08) : 699 - 702
  • [8] Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
    Faustino, Celia
    Pinheiro, Lidia
    [J]. PHARMACEUTICS, 2020, 12 (01)
  • [9] Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations
    Frezard, Frederic
    Aguiar, Marta M. G.
    Ferreira, Lucas A. M.
    Ramos, Guilherme S.
    Santos, Thais T.
    Borges, Gabriel S. M.
    Vallejos, Virginia M. R.
    De Morais, Helane L. O.
    [J]. PHARMACEUTICS, 2023, 15 (01)
  • [10] Antifungal Treatment for Pityriasis Versicolor
    Gupta, Aditya K.
    Foley, Kelly A.
    [J]. JOURNAL OF FUNGI, 2015, 1 (01) : 13 - 29